SOUTH SAN FRANCISCO, Calif., April 4, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc.
I intend to review the company’s Q2 earnings and will highlight some of the bullish themes for investors. In addition, I will point out some risks that investors need to consider when managing their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback